Just letting subscribers know we’ve posted more information on Auxly’s ‘missing’ inventory over in the ‘Discussion’ area of our website.

We haven’t heard back from Auxly on this yet. Our initial analysis seems to hold, and we’ve looked at this from several directions. It appears to stem from a booking to ‘Biological Assets’ in their 3rd quarter.

By all appearances, it looks like an accounting error. If so, a restatement might not be far behind.

Perhaps we’ve missed something. We’ll let you know as soon as we get a response.

The preceding is the opinion of the author, and is in no way intended to be a recommendation to buy or sell any security or derivative. The author holds no position in $XLY